window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Liza

  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Isomab data support safety of angiogenic approaches in coronary artery disease

    A systematic review of more than two decades of clinical [...]

    September 4, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    FDA approves Tivicay PD for children with HIV weighing at least 2kg

    ViiV Healthcare has received US FDA approval for Tivicay PD [...]

    September 4, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Tezspire meets Phase 3 endpoints in eosinophilic esophagitis

    AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]

    August 28, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain

    Brenntag signs Eastern Europe nutraceutical distribution deal

    Brenntag has signed an exclusive distribution agreement with Zeus Hygia [...]

    August 28, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics

    FDA approves daraxonrasib for second-line pancreatic cancer

    The US FDA has approved Revolution Medicines’ daraxonrasib for adults [...]

    August 28, 2026
  • Biotech & Pharma Business,Digital & Data

    PharmaForceIQ launches AI platform for pharma commercial teams

    PharmaForceIQ has launched Optichannel 360, an AI platform that connects [...]

    August 28, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics

    Biogen’s felzartamab approved in China for multiple myeloma

    Biogen’s felzartamab has been approved in China as a treatment [...]

    August 27, 2026
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    Agenus reports deep responses with immunotherapy in Phase 2 colon cancer study

    Agenus has reported deep tumour responses and no observed colorectal [...]

    August 27, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development

    CEPI funds Minapharm’s Phase 1 Bundibugyo Ebola vaccine programme

    CEPI will provide up to $16.5 million to Minapharm to [...]

    August 27, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    Sagimet prepares Phase 3 acne trial for first US patients

    Sagimet Biosciences is preparing to begin screening patients for its [...]

    August 27, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Piramal Pharma reports 22.6% emissions reduction and zero OAI observations in sustainability report
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Research & Development
  • FDA approves ViiV’s Tivicay PD for young children with HIV
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Centrix and University of Sussex launch £375,000 data science project for drug development
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development, Manufacturing & Supply Chain, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top